TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH PRAVASTATIN (CS-514) AND OR CHOLESTYRAMINE - (THE SPANISH MULTICENTER PRAVASTATIN STUDY)

被引：0
|
作者：
CARMENA, R
DEOYA, M
FRANCO, M
MARTINEZ, M
MATA, P
GOMEZ, J
SERRANO, S
ALVAREZSALA, L
MATESANZ, J
RUBIO, M
GRAS, X
机构：
来源：
ATHEROSCLEROSIS VIII | 1989年 / 817卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：757 / 760
页数：4
相关论文
共 50 条
  • [1] Pravastatin, cholestyramine, and bezafibrate in patients with heterozygous familial hypercholesterolemia: The Spanish multicenter pravastatin study
    Carmena, R
    DeOya, M
    GomezGerique, J
    Mata, P
    Serrano, S
    Franco, M
    MartinezTriguero, ML
    AlvarezSala, L
    Matesanz, J
    Rubio, MJ
    Gras, X
    Olivan, J
    CARDIOVASCULAR RISK FACTORS, 1996, 6 (01): : 55 - 61
  • [2] USEFULNESS OF COMBINED TREATMENT WITH CS-514(CS), PROBUCOL(PB) AND CHOLESTYRAMINE(CA) IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA(FH)
    NAKAMURA, T
    MATSUZAWA, Y
    FUNAHASHI, T
    YAMASHITA, S
    KUBO, M
    HIROBE, K
    NAKAJIMA, T
    TARUI, S
    ARTERIOSCLEROSIS, 1988, 8 (05): : A591 - A591
  • [3] EFFECT OF CS-514 (PRAVASTATIN) ON VLDL-TRIGLYCERIDE KINETICS IN RATS
    YOSHINO, G
    KAZUMI, T
    KASAMA, T
    IWAI, M
    IWATANI, I
    MATSUBA, K
    MATSUSHITA, M
    BABA, S
    ATHEROSCLEROSIS, 1988, 73 (2-3) : 191 - 195
  • [4] TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA - UNITED-KINGDOM LIPID CLINICS STUDY OF PRAVASTATIN AND CHOLESTYRAMINE
    BETTERIDGE, DJ
    BHATNAGER, D
    BING, RF
    DURRINGTON, PN
    EVANS, GR
    FLAX, H
    JAY, RH
    LEWISBARNED, NL
    MANN, J
    MATTHEWS, DR
    MILLER, JP
    RECKLESS, JPD
    STURLEY, R
    TAYLOR, KG
    WINDER, AF
    BRITISH MEDICAL JOURNAL, 1992, 304 (6838): : 1335 - 1338
  • [5] INDUCTION OF MESSENGER-RNA FOR LOW-DENSITY LIPOPROTEIN RECEPTORS IN HETEROZYGOUS WATANABE HERITABLE HYPERLIPIDEMIC RABBITS TREATED WITH CS-514 (PRAVASTATIN) AND CHOLESTYRAMINE
    KUME, N
    KITA, T
    MIKAMI, A
    YOKODE, M
    ISHII, K
    NAGANO, Y
    KAWAI, C
    CIRCULATION, 1989, 79 (05) : 1084 - 1090
  • [6] Comparison of pravastatin alone and with cholestyramine in the treatment of hypercholesterolemia
    Tsai, CH
    Ding, YA
    Hao, KL
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 1995, 19 (02) : 115 - 121
  • [7] COMPARATIVE EFFECTS OF SIMVASTATIN (MK-733) AND PRAVASTATIN (CS-514) ON HYPERCHOLESTEROLEMIA INDUCED BY CHOLESTEROL FEEDING IN RABBITS
    ISHIDA, F
    WATANABE, K
    SATO, A
    TAGUCHI, K
    KAKUBARI, K
    KITANI, K
    KAMEI, T
    BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1042 (03) : 365 - 373
  • [8] EFFECTS OF PRAVASTATIN AND CHOLESTYRAMINE ON STEROID-HORMONES IN FAMILIAL HYPERCHOLESTEROLEMIA
    JAY, RH
    STURLEY, RH
    STIRLING, C
    MCGARRIGLE, HHG
    KATZ, M
    RECKLESS, JPD
    BETTERIDGE, DJ
    ATHEROSCLEROSIS, 1991, 90 (2-3) : 227 - 227
  • [9] EFFECTS OF PRAVASTATIN AND CHOLESTYRAMINE ON PRODUCTS OF THE MEVALONATE PATHWAY IN FAMILIAL HYPERCHOLESTEROLEMIA
    ELMBERGER, PG
    KALEN, A
    LUND, E
    REIHNER, E
    ERIKSSON, M
    BERGLUND, L
    ANGELIN, B
    DALLNER, G
    JOURNAL OF LIPID RESEARCH, 1991, 32 (06) : 935 - 940
  • [10] EFFECTS OF PRAVASTATIN (CS-514) ON BILIARY LIPID-METABOLISM IN PATIENTS WITH HYPERLIPIDEMIA
    HORIUCHI, I
    OHYA, T
    TAZUMA, S
    MIZUNO, T
    TAKIZAWA, I
    KAJIYAMA, G
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (03): : 226 - 230
12345